The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
Muscular Dystrophy Association
3300 East Sunrise Drive
Tucson, AZ 85718-3208
Established in 1950, the Muscular Dystrophy Association (MDA) is a non-profit, voluntary health agency dedicated to providing comprehensive medical services to individuals affected by over 40 neuromuscular diseases. MDA provides these services at some 230 hospital-affiliated clinics across the United States. The association's worldwide research program allocates more than $28 million a year, seeking cures and treatments for neuromuscular disorders. MDA funds some 400 individual scientific investigations each year at a cost of $57 a minute, around the clock. This represents the largest single initiative to advance current knowledge of neuromuscular diseases and to find cures and treatments for this group of diseases.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.